ASCEND
BY NTHRYS

NTHRYSInternshipsAi Drug Repurposing

AI Cancer Drug Repurposing Pipeline

Ai Drug Repurposing
AI Cancer Drug Repurposing Pipeline
Focused area
Variant
Pay · Join
Step 3 of 5Choose focused area
Field
Category
Focused area
You might prefer
AI Knowledge Graph Drug Repurposing ResearchMachine Learning Omics-Driven Repurposing StudiesAI Drug Repurposing for Rare Disease ResearchDeep Learning for Drug Side Effect RepurposingAI Literature Mining for Repurposing SignalsAI Polypharmacology-Based Repurposing ResearchAI Patient Data-Driven Drug Repurposing ResearchAI Pandemic Drug Repurposing Response ResearchAI Network Medicine Drug Repurposing ResearchAI Combination Therapy Repurposing StudiesAI Molecular Docking Drug RepurposingGraph Neural Networks Drug Target PredictionTransformer Models Biomedical Text MiningFederated Learning Drug Discovery NetworksSMILES-Based Drug Representation LearningAI Antimicrobial Resistance Drug RepurposingClinical Trial Data Mining RepurposingAI Neurodegenerative Disease RepurposingReinforcement Learning Drug OptimizationProtein Structure AI Drug RepurposingAI Cardiovascular Drug Repurposing ResearchChemical Similarity Network Drug DiscoveryMulti-Task Learning Disease PredictionAI Inflammatory Disease Drug RepurposingSequence-Based Protein Target DiscoveryMetabolomics Data Integration Drug RepurposingAI Infectious Disease Drug RepurposingTransfer Learning Drug Response PredictionAI Autoimmune Disease Drug RepurposingGene Expression Drug Response ModelingAI Metabolic Disease Drug RepurposingAttention Mechanisms Drug Target RankingAI Pulmonary Disease Drug RepurposingPharmacophore Matching AI Drug DiscoveryAI Renal Disease Drug RepurposingSynthetic Data Generation Drug TrainingAI Gastrointestinal Disease Drug RepurposingCausal Inference Drug Effect AttributionAI Ophthalmologic Drug RepurposingTemporal Disease Progression Drug ModelingAI Dermatological Drug Repurposing ResearchCross-Species Drug Efficacy TranslationAI Orthopedic Disease Drug RepurposingExplainable AI Drug Repurposing ModelsAI Endocrine Disease Drug RepurposingZero-Shot Learning Drug RepurposingAI Psychiatric Drug Repurposing StudiesVariational Autoencoder Drug DiscoveryAI Biomarker Discovery Drug Repurposing

AI Cancer Drug Repurposing Pipeline

Intern will build end-to-end AI pipelines integrating genomics data and drug response prediction to identify cancer drug repurposing opportunities.

The focused areas below are internship topics in varied working formats. Pick one, then choose your internship type, mode… Read more

🎓 TYPE
🌐 MODE
📚 Academic: Thesis & PPT assistance included🧪 Tech: Master the protocols hands-on📝 Research > 3 months: Publication co-authorship in a Scopus-indexed journal
🔍

Showing 110 of 10

Machine Learning Protein Structure Prediction for Oncology
Research investigates how deep learning models predict cancer protein targets and their binding mechanisms using structural biology data. This generates novel insights into how existing drug molecules can interact with previously unexplored cancer pathways.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £793
R · £1,154
3 Months
A · £1,043
T · £1,275
R · £1,854
6 Months
A · £2,317
T · £2,832
R · £4,119
14 more durationsView Titles →
Graph Neural Networks for Drug-Target Interaction Mapping
Study examines graph-based neural architectures to model complex relationships between pharmaceutical compounds and cancer-related protein networks. The research produces predictive frameworks identifying hidden therapeutic connections between approved drugs and new oncology targets.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £803
R · £1,167
3 Months
A · £1,055
T · £1,290
R · £1,875
6 Months
A · £2,344
T · £2,865
R · £4,167
14 more durationsView Titles →
Transfer Learning Across Cancer Genomic Datasets
Research applies pre-trained AI models to identify cancer mutations that respond to existing drug therapies across heterogeneous tumor types. This generates cross-cancer insights enabling drug repurposing strategies for rare and understudied malignancies.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £766
R · £1,113
3 Months
A · £1,006
T · £1,230
R · £1,789
6 Months
A · £2,236
T · £2,733
R · £3,975
14 more durationsView Titles →
Natural Language Processing of Oncology Literature Mining
Study uses advanced NLP techniques to extract hidden associations between drug mechanisms, cancer biology, and clinical outcomes from published research. The research produces comprehensive knowledge graphs revealing overlooked repurposing opportunities from scientific literature.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £796
R · £1,158
3 Months
A · £1,047
T · £1,280
R · £1,861
6 Months
A · £2,326
T · £2,843
R · £4,135
14 more durationsView Titles →
Federated Learning for Multicenter Cancer Drug Data
Research develops decentralized AI models training across multiple hospital networks'' cancer patient datasets without centralizing sensitive information. This generates privacy-preserving insights into how drugs perform across diverse patient populations and tumor subtypes.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £793
R · £1,154
3 Months
A · £1,043
T · £1,275
R · £1,854
6 Months
A · £2,317
T · £2,832
R · £4,119
14 more durationsView Titles →
Reinforcement Learning for Rational Drug Combination Design
Study employs reinforcement learning agents to discover optimal combinations of repurposed drugs that overcome cancer resistance mechanisms. The research produces computational strategies identifying synergistic drug pairs reducing tumor heterogeneity.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £809
R · £1,176
3 Months
A · £1,063
T · £1,299
R · £1,890
6 Months
A · £2,362
T · £2,887
R · £4,199
14 more durationsView Titles →
Metabolic Network Analysis via Systems Pharmacology
Research investigates how AI-driven metabolic modeling predicts cancer cell dependencies exploitable by existing pharmaceutical agents. This generates mechanistic understanding of how repurposed drugs disrupt oncogenic metabolic pathways.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £784
R · £1,140
3 Months
A · £1,031
T · £1,260
R · £1,832
6 Months
A · £2,290
T · £2,799
R · £4,071
14 more durationsView Titles →
Explainable AI for Cancer Drug Mechanism Elucidation
Study develops interpretable machine learning models that reveal why specific drugs show unexpected efficacy against particular cancer types. The research produces trustworthy predictions and mechanistic insights accelerating clinical validation of repurposed therapies.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £753
R · £1,095
3 Months
A · £990
T · £1,210
R · £1,760
6 Months
A · £2,200
T · £2,689
R · £3,911
14 more durationsView Titles →
Temporal Deep Learning for Treatment Response Prediction
Research applies sequential neural networks to patient biomarker trajectories predicting which repurposed drugs optimize individual cancer outcomes. This generates personalized medicine insights matching drugs to patient-specific tumor evolution patterns.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £824
R · £1,199
3 Months
A · £1,084
T · £1,324
R · £1,926
6 Months
A · £2,407
T · £2,942
R · £4,279
14 more durationsView Titles →
Multimodal Embedding Spaces for Drug-Cancer Phenotype Alignment
Study creates unified vector representations integrating drug chemistry, cancer genomics, and clinical phenotypes through transformer architectures. The research produces semantic spaces where similar drugs and cancer types cluster, revealing novel repurposing candidates.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £790
R · £1,149
3 Months
A · £1,039
T · £1,270
R · £1,847
6 Months
A · £2,308
T · £2,821
R · £4,103
14 more durationsView Titles →